AMERISAFE Stock Forecast, Price & News

AMERISAFE's stock was trading at $60.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMSF stock has decreased by 6.6% and is now trading at $56.97.
View which stocks have been most impacted by COVID-19.

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMERISAFE stock.
View analyst ratings for AMERISAFE or view MarketBeat's top 5 stock picks.

Wall Street analysts have given AMERISAFE a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AMERISAFE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

18 employees have rated AMERISAFE CEO Janelle Frost on Glassdoor.com. Janelle Frost has an approval rating of 79% among AMERISAFE's employees.

AMERISAFE is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for AMERISAFE.

AMERISAFE will be holding an earnings conference call on Wednesday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

AMERISAFE, Inc. (NASDAQ:AMSF) issued its earnings results on Monday, November, 2nd. The insurance provider reported $1.16 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.72 by $0.44. The insurance provider earned $81.85 million during the quarter, compared to analyst estimates of $83.05 million. AMERISAFE had a trailing twelve-month return on equity of 20.22% and a net margin of 26.84%.
View AMERISAFE's earnings history.

AMERISAFE announced a None dividend on Wednesday, October 28th. Investors of record on Wednesday, November 11th will be paid a dividend of $3.50 per share on Wednesday, November 18th. The ex-dividend date is Monday, November 9th.
View AMERISAFE's dividend history.

AMERISAFE pays an annual dividend of $1.08 per share and currently has a dividend yield of 1.92%. The dividend payout ratio of AMERISAFE is 23.48%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AMERISAFE will have a dividend payout ratio of 36.99% next year. This indicates that AMERISAFE will be able to sustain or increase its dividend.
View AMERISAFE's dividend history.

3 brokers have issued 1-year target prices for AMERISAFE's stock. Their forecasts range from $72.00 to $80.00. On average, they expect AMERISAFE's stock price to reach $76.00 in the next year. This suggests a possible upside of 33.4% from the stock's current price.
View analysts' price targets for AMERISAFE or view Wall Street analyst' top-rated stocks.

Some companies that are related to AMERISAFE include (BRK.B) (BRK.B), The Progressive (PGR), The Travelers Companies (TRV), The Allstate (ALL), Cincinnati Financial (CINF), Markel (MKL), Arch Capital Group (ACGL), W. R. Berkley (WRB), Fidelity National Financial (FNF), Erie Indemnity (ERIE), CNA Financial (CNA), First American Financial (FAF), Old Republic International (ORI), RLI (RLI) and The Hanover Insurance Group (THG).
View all of AMSF's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

AMERISAFE trades on the NASDAQ under the ticker symbol "AMSF."

AMERISAFE's stock is owned by many different institutional and retail investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (0.77%), State of Alaska Department of Revenue (0.08%), Nisa Investment Advisors LLC (0.08%) and Exchange Traded Concepts LLC (0.03%). Company insiders that own AMERISAFE stock include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, Randy Roach and Vincent J Gagliano.
View institutional ownership trends for AMERISAFE.

AMSF stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Smith Graham & Co. Investment Advisors LP. Company insiders that have sold AMERISAFE company stock in the last year include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, and Vincent J Gagliano.
View insider buying and selling activity for AMERISAFE or view top insider-selling stocks.

AMSF stock was purchased by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, and Nisa Investment Advisors LLC.
View insider buying and selling activity for AMERISAFE or or view top insider-buying stocks.

Shares of AMSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AMSF stock can currently be purchased for approximately $56.97.

AMERISAFE has a market capitalization of $1.10 billion and generates $370.37 million in revenue each year. The insurance provider earns $92.69 million in net income (profit) each year or $4.60 on an earnings per share basis. AMERISAFE employs 431 workers across the globe.

The official website for AMERISAFE is www.amerisafe.com.

AMERISAFE's mailing address is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. The insurance provider can be reached via phone at 337-463-9052 or via email at [email protected]